Introduction
In the first paper of this supplement, three topics will be addressed: the creation and current status of the Pennington Biomedical Research Center, the aims of the 20th Anniversary Conference and the progress made in obesity research over the last few decades.
The Pennington Biomedical Research Center
At the age of 80 years, Claude B (Doc) Pennington and his wife, Irene W Pennington, pledged a large donation to the Louisiana State University System. Doc Pennington, an oilman living in Baton Rouge, Louisiana, wanted a biomedical research center established in this city. After much deliberation, the Pennington Biomedical Research Center (PBRC) was created with the mission of 'promoting healthier lives through research and education in nutrition and preventive medicine.'
A few years later, five buildings totaling about 21 000 m 2 had been erected: an administrative building, inpatient and outpatient clinics, a basic laboratory wing, an animal care facility and a physical plant. In 1988, LSU Boyd Professor William Pryor, PhD, began serving as interim Executive Director of the Center, with Mr William Silvia as Associate Director. In the same year, after a national search had been undertaken for a full-time director, George Bray, MD, an internationally known specialist in obesity, diabetes and metabolism at the University of Southern California, was appointed as the Center's first Executive Director. Soon afterwards, the Center's two main research areas were headed by Donna Ryan, MD (Clinical Research) and David York, PhD (Basic Research). PBRC became an independent campus of the LSU System in the early 1990s.
By the mid-1990s, a 10 000 m 2 expansion was completed with three new buildings: the CB Claude Pennington, Jr, Conference and Education Center, a guest lodge and an exercise research facility that lined the bank of a newly constructed lake. The Center's first endowed chair, the Claude B Pennington, Jr, Chair, was awarded to Leslie Kozak, PhD. The PBRC has considerable assets in the pursuit of its mission. It now benefits from the research activities of more than 80 faculty, 40 postdoctoral fellows, 65 adjunct faculty and more than 400 support staff. The Center operates 19 core facilities and 53 laboratories in basic research, clinical research and population science. It enjoys the support of 11 endowed chairs, three NIH-funded research centers, a partnership with USDA, two foundations established for the sole purpose of helping the Center, a venture fund and sustained financial contribution from the State of Louisiana. Funding is currently in place to add about 30% more research space to the Center's resources.
The year 2008 marks the 20th Anniversary of the opening of PBRC. The Center is clearly poised to make even more significant contributions to our understanding of the complex nature of disease prevention and the unique role played by nutrition. Obesity has been one of the strongest research program areas of PBRC from the beginning. It is therefore quite appropriate that the main theme of the 20th Anniversary conference be on obesity research and the ongoing obesity epidemic.
Aims of the conference
The planning committee for the conference was composed of Drs George Bray, Leslie Kozak, Eric Ravussin and Claude Bouchard. An early consensus was reached on the overarching theme of the event: it would review the most important advances in the field. A total of about 50 major advances was identified by the committee as having taken place over the last few decades in the many research areas presenting a relation with obesity. An attempt was made to parcel these advances to the major components of the obesity research continuum, and these components are displayed in Figure 1 . The continuum extends from measurement, genetics and metabolism to epidemiology, public policy and prevention.
Because of time constraints, only 20 topics of the 50 or so identified by the committee could be adequately covered in the program of the conference. We fully understand that other scientists could have come up with a different listing. However, it is our view that the 20 topics retained represent some of the most, if not the most, important advances in the field of obesity research in modern time. The advances highlighted in the final program of the conference have made major differences in our current understanding of adipogenesis, central and peripheral regulation of body weight, the health consequences of excess body weight, the challenges of weight loss, the magnitude of the worldwide epidemic, and the impact of public health policies to name but a few.
Progress made in obesity research
One of the most important sources of information for the assessment of the progress made in obesity research in Not only has the volume of research expanded considerably but also the scope and depth of the obesity science has grown enormously, as revealed by these publications. However, despite all the progress made over the three decades covered by these international meetings and related publications, many of the questions that were considered in the 1960s and 1970s are still not fully resolved today. Another line of evidence for the growth of obesity research is to quantify the publication rates in a number of areas. This is what we have done by decades beginning in the 1960s up to 2008, and the data gathered from PubMed are summarized in Table 1 . All aspects have received growing attention in the scientific literature, as revealed by the number of papers published across the six time points. Interestingly, all topics have been addressed in many more publications over the last 6 years or so compared with the previous decade with the exception of brown adipose tissue.
I will now comment briefly on some areas or issues for which major advances have been made. Needless to say, many other topics could have been addressed in this overview but I have chosen to focus only on six in the present setting.
Measurement and evaluation of obesity Fifty years ago, there was no standardized and internationally recognized method to measure and evaluate what is normal weight, overweight, or obesity. Several methods were used based on weight and height, including the body mass index, the ponderal index, weight-for-height, relative weight and others. It was not until the landmark contribution of the International Obesity Task Force in 1996 and the adoption of the body mass index recommended standards first by the World Health Organization 10 and then by the National Heart, Lung and Blood Institute of the National Institutes of Health of the USA 11 that an accepted and internationally recognized method with evaluation standards began to be used. The worldwide acceptance of the WHO/NHLBI/IOTF standards made an enormous difference in terms of data reporting coherence, clinical standards, population comparisons and so on. Thus, we have seen a wealth of new publications on secular differences in overweight and obesity prevalence within many countries of the developed and even the developing world, ethnic comparisons, the relationships between weight classification and health outcomes, costs of health-care services and body mass index classes and on other critical population issues. As shown in Table 1 , the number of papers using body mass index has grown exponentially over the last few decades.
Measurement of body composition and fat distribution
As is evident from the paper by S Heymsfield later in this supplement, we have made great strides forward in our ability to measure not only total body adiposity but also overall body composition. Jean Vague 12 was undoubtedly among the first to suggest that fat topography was important to consider in the assessment of the obesity risk profile. Although Professor Vague was a visionary, his approach was not exclusively focused on fat distribution (it also included a muscular component) and was in retrospect complex but rudimentary, certainly by today's standard. The whole issue gained acceptance in the 1980s primarily with the series of papers published by professors Per Bjorntorp (Sweden), Ahmed Kissebah (USA), Jean-Pierre Despres (Canada) and Yuji Matsuzawa (Japan) (see his paper in this supplement). Imaging technologies made it possible to distinguish between various fat depots, including abdominal visceral In some cases, synonymous terms were searched. To avoid duplication, the higher total in each decade was used. For example, both body mass index and Quetelet index were used as terms. In 1981-1990, Quetelet index was higher than body mass index (2639 vs 2475) but lower in 1991-2000 (20 573 vs 21 449). In both cases, the highest number was used. Other synonym sets are (1) visceral fat and visceral adipose tissue and (2) bariatric surgery and obesity surgery.
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Adipose tissue biology
This is an area of research that has always been central to the efforts to understand obesity, which was long thought to be primarily a disease of adipose tissue. The issue of fat cell size and number across the lifespan, in normal weight and obese people, and across fat depots was investigated in many laboratories in the 1960s and 1970s. The laboratories of Jules Hirsch (USA), Per Bjorntorp (Sweden), Mario Di Girolamo (USA), to name but a few, were quite active in this area. The effort shifted quickly to adipose tissue and fat cell metabolism, and Max Lafontan (France), Peter Arner (Sweden), Robert Eckel (USA), Rudy Leibel (USA), Susan Fried (USA), Philip Kern (USA), Michael Jensen (USA) and Hans Hauner (Germany) were among those who made important contributions. All along, another research area grew with a focus on the molecules involved in the developmental biology of the adipocytes, the sequences of events leading from the preadipocyte stage to the mature fat cell, the key molecules in driving this differentiation process, and then the transcription factors, co-activators, repressors, and genes transcribed at various time points. Many laboratories contributed to this effort but those of Howard Green (USA), Gerald Ailhaud (France), and Bruce Spiegelman (USA) were among the few that made high impact contributions. In this regard, Dr Spiegelman was one of the speakers at the conference but was unable to deliver a manuscript. However, for the record, his presentation dealt with the transcriptional pathways controlling energy expenditure through regulation of mitochondrial function, using brown adipose cells as a rich source from which to 'mine' molecules with broad roles in these processes. The role of the PGC-1 transcriptional co-activators in regulating mitochondrial respiration in brown fat and many other tissues was discussed. New data from his laboratory suggest that these molecules also coordinate mitochondrial biogenesis with angiogenesis, providing a novel pathway to influence tissue respiration and ischemia/reperfusion injury. He also presented data indicating that PRDM16 is a 'master' regulator of the determination of brown fat cell fate. PRDM 16 can alter the gene expression pattern of white fat precursor cells, so that they differentiate into brown fat cells. Expression of short hairpin-RNA against PRDM16 in immortalized brown fat cells shows that PRDM16 is required for essentially the entire brown fat program. Interestingly, when the same short hairpin-RNA against PRDM16 is expressed in primary brown preadipose cells, these cells differentiate into muscle cells, strongly suggesting a relationship between brown fat and skeletal muscle.
In recent times, the field of adipose tissue biology has continued to generate a wealth of discoveries that have made a strong impact on obesity research. The discovery of leptin by the Rockefeller team of Jeffrey Friedman 13 was a turning point in this regard. More than 14 000 papers have been published on leptin biology since the 1994 landmark paper. The same is true of adiponectin, which has received a great deal of attention after it was isolated as a result of the joint efforts of a few laboratories, particularly those of Harvey Lodish (USA), Yuji Matsuzawa (Japan), Bruce Spiegelman (USA) and Motowo Tomita (Japan). Several scientists have contributed to our understanding of the role of white adipose tissue and fat cells as organs capable of secreting many molecules with implications for metabolic homeostasis. The metabolic cross talk does not take place only between skeletal muscle, and liver but rather among adipose tissue, muscle, and liver plus the gastrointestinal tract and the brain. Figure 2 provides an overview of the adipocytes/adipose tissue secreted molecules. Among the most important developments of the last decade in adipose tissue biology, one finds the observation that adipose tissue plays a strong role in inflammatory processes. At the conference, this topic was addressed by Gokhan Hotamisligil (USA) who is making many contributions to this field, including the relations between obesity and inflammation and how they interact in the development of insulin resistance and other diseases.
Genetics
Interests for the potential role of genetic factors in obesity can be traced far back in time. Late in the 19th century, we saw the first papers dealing with weight and corpulence in twins. In the 1930s, several papers were published on the prevalence of obese offspring in families with obese parents. Beginning with the 1970s, the focus of studies on the genetics of obesity shifted to genetic heritability, major gene effects, maternal and paternal effects, sex-specific effects, assortative mating, and other genetic epidemiology questions. It was then noted that there were large differences in heritability estimates depending on the design used to generate them: the highest estimates came from twin studies and the lowest from adoption designs, with nuclear families providing intermediary values. Many laboratories contributed to this body of knowledge including those of Albert Stunkard (USA), Thorkild Sorensen (Denmark), David Allison (USA), and Arlen Price (USA), to name but a few. In 1990, Neil Risch proposed to use the lambda coefficient to quantify the level of risk when someone has affected biological relatives compared with the prevalence of a condition in the population at large. 14 Several papers have been published on the familial risk of overweight and obesity, and they all revealed that lambda or its ratio equivalent increases with the severity of the excess weight. Three intervention studies performed with pairs of identical twins confirmed that there was a latent and most likely inherited predisposition to gain Progress in obesity research C Bouchard adipose tissue and weight when exposed to a standard amount of excess energy 15 or to lose fat mass and weight when exposed to negative energy balance conditions. 16, 17 The focus of research evolved rapidly to an emphasis on candidate genes, positional candidates, single-gene disorders, quantitative trait loci from genomic scans and DNA polymorphisms. There was intense cross talk between rodent genetic models and human clinical cases, particularly when it came to single-gene defects. Rodent models informed severe human obesity cases, and in turn the latter informed the underlying physiopathology. The sequence of the human genome became available, and it fueled even more interest and growth. Among those who contributed the most to our advances in this area, one can recognize Stephen O'Rahilly (UK), Sadaf Farooqi (UK), Philippe Froguel (France), Karine Clement (France) and Rudy Leibel (USA) among others. Then the sequencing and genotyping technologies improved dramatically, and the HapMap project delivered a compendium of the haploblocks and tagSNPs of the human genome. Genome-wide association mapping became possible with hundreds of thousands and even millions of single-nucleotide polymorphisms. Within a few months, many new candidate genes were identified for common chronic diseases, and obesity took part in this growth. The FTO gene is the direct product of these recent advances. It has been found and confirmed in many studies with large sample sizes that one copy of the FTO risk allele increases the risk of obesity by about 30% and two copies by as much as 60%, although the FTO effect size is very small. 18 Bariatric surgery A surgical treatment for obesity was originally conceived in the 1950s. The first operation was an intestinal bypass, which resulted in a short gut syndrome. 19 Bariatric surgery has now become one of the major surgical procedures practiced in the developed world, particularly in the United States. 20 Laparoscopic procedures became commonly practiced in obese patients in the late 1990s. Bariatric surgery has become the most reliable method to induce a major sustained weight loss. It has become clear over the last few years that the weight loss induced by almost any of the surgical procedures was accompanied by substantial improvements in the diabetes and cardiovascular disease risk profile. 21 In particular, it has been observed by several groups that the decrease in insulin resistance and the reduction of the risk for type 2 diabetes mellitus occurs within a few days after the surgical intervention. Because of the diversity of surgical procedures, there is an opportunity to investigate in depth in people the specific contributions of changes in substrate metabolism and gut signaling in addition to rate of weight loss to the improved metabolic profile. More recently, Progress in obesity research C Bouchard
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Lars Sjostrom (Sweden) and collaborators have shown that bariatric surgery was associated with reduced mortality after an average 11 years of follow-up in the SOS cohort (see paper in this supplement and Sjostrom et al. 22 ). With further advances in laparoscopic methods, one can predict that the number of obese patients consenting to bariatric surgery will continue to rise substantially, at least until adequate pharmacotherapies become available. As shown in Table 1 , almost 8000 papers have been published on bariatric surgery in the medical literature, the majority in the present decade.
Public policy
It took a long time before it was realized that obesity is not solely a matter of individual responsibility. This concept was brought forward forcefully in the report of the International Obesity Task Force and provided much of the foundation for the WHO consultation on obesity. 10 By that time, a whole body of data indicated that factors in the social and the built environment had significant influences on body weight and its fluctuation over time. In addition, there were countless studies showing that relapse after weight loss happens typically when individuals revert to their original environment and lifestyle. Today we take for granted that public policies are needed to curtail the ongoing epidemic of overweight and obesity around the world. However, some are still offering resistance to the notion that advertising, agriculture and farm policies, food labeling, food programs for schools, urban design, public transport system, walking and cycling lanes and trails, building codes, and other social and built environment determinants limit ultimately the choice that individuals can make and influence the risk of lifestyle-related diseases. The default behavioral option is too seldom the healthy option. Many colleagues around the world have contributed to the recent increase in awareness regarding the importance of public policy to address the obesity epidemic. Among them, Philip James (UK), Neville Rigby (UK), Tim Lobstein (UK), Boyd Swinburn (Australia), William Dietz (USA), Kelly Brownell (USA), and Shiriki Kumanyika (USA) have played a major role.
Content of this supplement
This Supplement to the journal includes this introduction and a concluding paper by Robert Eckel, MD, plus 21 of the 22 major papers presented at the conference.
